• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全国范围内 2 型糖尿病合并症预测。

Nationwide prediction of type 2 diabetes comorbidities.

机构信息

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

出版信息

Sci Rep. 2020 Feb 4;10(1):1776. doi: 10.1038/s41598-020-58601-7.

DOI:10.1038/s41598-020-58601-7
PMID:32019971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7000818/
Abstract

Identification of individuals at risk of developing disease comorbidities represents an important task in tackling the growing personal and societal burdens associated with chronic diseases. We employed machine learning techniques to investigate to what extent data from longitudinal, nationwide Danish health registers can be used to predict individuals at high risk of developing type 2 diabetes (T2D) comorbidities. Leveraging logistic regression-, random forest- and gradient boosting models and register data spanning hospitalizations, drug prescriptions and contacts with primary care contractors from >200,000 individuals newly diagnosed with T2D, we predicted five-year risk of heart failure (HF), myocardial infarction (MI), stroke (ST), cardiovascular disease (CVD) and chronic kidney disease (CKD). For HF, MI, CVD, and CKD, register-based models outperformed a reference model leveraging canonical individual characteristics by achieving area under the receiver operating characteristic curve improvements of 0.06, 0.03, 0.04, and 0.07, respectively. The top 1,000 patients predicted to be at highest risk exhibited observed incidence ratios exceeding 4.99, 3.52, 1.97 and 4.71 respectively. In summary, prediction of T2D comorbidities utilizing Danish registers led to consistent albeit modest performance improvements over reference models, suggesting that register data could be leveraged to systematically identify individuals at risk of developing disease comorbidities.

摘要

识别有发展为疾病合并症风险的个体是应对与慢性疾病相关的个人和社会负担不断增加的重要任务。我们采用机器学习技术来研究丹麦全国纵向健康登记数据在多大程度上可以用于预测有发展为 2 型糖尿病(T2D)合并症风险的个体。利用逻辑回归、随机森林和梯度提升模型以及登记数据,涵盖了 20 多万名新诊断为 T2D 的个体的住院、药物处方和与初级保健承包商的接触情况,我们预测了五年内心力衰竭(HF)、心肌梗死(MI)、中风(ST)、心血管疾病(CVD)和慢性肾病(CKD)的风险。对于 HF、MI、CVD 和 CKD,基于登记的模型的表现优于利用典型个体特征的参考模型,分别实现了 0.06、0.03、0.04 和 0.07 的接收者操作特征曲线下面积的改善。预测为风险最高的前 1000 名患者的观察发病率比分别超过 4.99、3.52、1.97 和 4.71。总之,利用丹麦登记数据预测 T2D 合并症导致参考模型的性能有了一致但适度的提高,这表明登记数据可用于系统地识别有发展为疾病合并症风险的个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/3ca911bf9503/41598_2020_58601_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/36cec6f0935f/41598_2020_58601_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/a1a5a6416f89/41598_2020_58601_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/5d2d48eb9707/41598_2020_58601_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/fdd5538b17e9/41598_2020_58601_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/3ca911bf9503/41598_2020_58601_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/36cec6f0935f/41598_2020_58601_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/a1a5a6416f89/41598_2020_58601_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/5d2d48eb9707/41598_2020_58601_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/fdd5538b17e9/41598_2020_58601_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b010/7000818/3ca911bf9503/41598_2020_58601_Fig5_HTML.jpg

相似文献

1
Nationwide prediction of type 2 diabetes comorbidities.全国范围内 2 型糖尿病合并症预测。
Sci Rep. 2020 Feb 4;10(1):1776. doi: 10.1038/s41598-020-58601-7.
2
Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.2型糖尿病及心力衰竭对预后的影响与其他心血管疾病的比较:一项全国性研究
Circ Cardiovasc Qual Outcomes. 2020 Jul;13(7):e006260. doi: 10.1161/CIRCOUTCOMES.119.006260. Epub 2020 Jun 23.
3
Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database.2 型糖尿病患者的心血管和肾脏疾病:首次发病表现和住院费用的 5 年累积发生率:法国全国索赔数据库 SNDS 中的一个队列。
Cardiovasc Diabetol. 2024 Jan 9;23(1):22. doi: 10.1186/s12933-023-02101-1.
4
Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals.2 型糖尿病患者心血管-肾脏疾病的终生风险:一项基于人群的在 473399 个人中的研究。
BMC Med. 2022 Feb 7;20(1):63. doi: 10.1186/s12916-022-02234-2.
5
Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.2型糖尿病且无既往心血管疾病患者的血压与并发症:基于全国人群的队列研究
BMJ. 2016 Aug 4;354:i4070. doi: 10.1136/bmj.i4070.
6
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.1型糖尿病与2型糖尿病患者心血管和肾脏疾病的患病率及发病率:一项法国全国性住院患者观察性研究
Diabetes Metab. 2023 May;49(3):101429. doi: 10.1016/j.diabet.2023.101429. Epub 2023 Feb 1.
7
Lower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.钠-葡萄糖共转运蛋白 2 抑制剂在无心血管和肾脏疾病的日本 2 型糖尿病患者中的使用与较低的心衰和慢性肾脏疾病风险相关。
Diabetes Obes Metab. 2021 Apr;23 Suppl 2:19-27. doi: 10.1111/dom.14119.
8
Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study.患有单纯性先天性心脏病患者的共病终生风险:一项丹麦全国性研究。
Eur Heart J. 2023 Mar 1;44(9):741-748. doi: 10.1093/eurheartj/ehac727.
9
External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.工具预测心血管疾病、2 型糖尿病或慢性肾脏病 7 年发病风险的外部验证。
J Gen Intern Med. 2018 Feb;33(2):182-188. doi: 10.1007/s11606-017-4231-7. Epub 2017 Dec 4.
10
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.钠-葡萄糖共转运蛋白 2 抑制剂的使用与主要心血管事件和心力衰竭风险:斯堪的纳维亚基于登记的队列研究。
BMJ. 2019 Aug 29;366:l4772. doi: 10.1136/bmj.l4772.

引用本文的文献

1
Electronic Health Records: A Gateway to AI-Driven Multimorbidity Solutions-A Comprehensive Systematic Review.电子健康记录:通往人工智能驱动的多重疾病解决方案的门户——一项全面的系统评价
J Clin Med. 2025 May 14;14(10):3434. doi: 10.3390/jcm14103434.
2
Predicting the risks of stroke, cardiovascular disease, and peripheral vascular disease among people with type 2 diabetes with artificial intelligence models: A systematic review and meta-analysis.使用人工智能模型预测2型糖尿病患者中风、心血管疾病和外周血管疾病的风险:一项系统综述和荟萃分析。
Narra J. 2025 Apr;5(1):e2116. doi: 10.52225/narra.v5i1.2116. Epub 2025 Mar 19.
3
Machine Learning-Driven Prediction of Comorbidities and Mortality in Adults With Type 1 Diabetes.

本文引用的文献

1
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models.系统评价显示,机器学习在临床预测模型中并未优于逻辑回归。
J Clin Epidemiol. 2019 Jun;110:12-22. doi: 10.1016/j.jclinepi.2019.02.004. Epub 2019 Feb 11.
2
Machine Learning for the Prediction of New-Onset Diabetes Mellitus during 5-Year Follow-up in Non-Diabetic Patients with Cardiovascular Risks.机器学习用于预测有心血管风险的非糖尿病患者5年随访期间新发糖尿病
Yonsei Med J. 2019 Feb;60(2):191-199. doi: 10.3349/ymj.2019.60.2.191.
3
Better medicine through machine learning: What's real, and what's artificial?
机器学习驱动的1型糖尿病成年患者合并症及死亡率预测
J Diabetes Sci Technol. 2024 Aug 2:19322968241267779. doi: 10.1177/19322968241267779.
4
Identifying subtypes of type 2 diabetes mellitus with machine learning: development, internal validation, prognostic validation and medication burden in linked electronic health records in 420 448 individuals.利用机器学习识别 2 型糖尿病亚型:在 420448 名个体的电子健康记录中进行开发、内部验证、预后验证和药物负担分析。
BMJ Open Diabetes Res Care. 2024 Jun 4;12(3):e004191. doi: 10.1136/bmjdrc-2024-004191.
5
Predicting Multimorbidity Using Saudi Health Indicators (Sharik) Nationwide Data: Statistical and Machine Learning Approach.利用沙特健康指标(Sharik)全国数据预测多重疾病:统计与机器学习方法
Healthcare (Basel). 2023 Jul 31;11(15):2176. doi: 10.3390/healthcare11152176.
6
Analysis of age-dependent gene-expression in human tissues for studying diabetes comorbidities.分析人类组织中与年龄相关的基因表达,以研究糖尿病合并症。
Sci Rep. 2023 Jun 26;13(1):10372. doi: 10.1038/s41598-023-37550-x.
7
Machine Learning for Predicting Micro- and Macrovascular Complications in Individuals With Prediabetes or Diabetes: Retrospective Cohort Study.机器学习预测糖尿病前期或糖尿病个体的微血管和大血管并发症:回顾性队列研究。
J Med Internet Res. 2023 Feb 27;25:e42181. doi: 10.2196/42181.
8
Cardiovascular complications in a diabetes prediction model using machine learning: a systematic review.基于机器学习的糖尿病预测模型中的心血管并发症:系统评价。
Cardiovasc Diabetol. 2023 Jan 19;22(1):13. doi: 10.1186/s12933-023-01741-7.
9
Risk stratification using Artificial Intelligence: Could it be useful to reduce the burden of chronic kidney disease in low- and middle-income Countries?使用人工智能进行风险分层:这对减轻低收入和中等收入国家的慢性肾脏病负担会有用吗?
Front Public Health. 2022 Sep 29;10:999512. doi: 10.3389/fpubh.2022.999512. eCollection 2022.
10
Commercial and Scientific Solutions for Blood Glucose Monitoring-A Review.商业和科学解决方案在血糖监测中的应用综述。
Sensors (Basel). 2022 Jan 6;22(2):425. doi: 10.3390/s22020425.
通过机器学习实现更好的医学:哪些是真实的,哪些是人为的?
PLoS Med. 2018 Dec 31;15(12):e1002721. doi: 10.1371/journal.pmed.1002721. eCollection 2018 Dec.
4
Development and validation of machine learning models to identify high-risk surgical patients using automatically curated electronic health record data (Pythia): A retrospective, single-site study.使用自动整理的电子健康记录数据(Pythia)开发和验证机器学习模型以识别高风险手术患者:一项回顾性、单站点研究。
PLoS Med. 2018 Nov 27;15(11):e1002701. doi: 10.1371/journal.pmed.1002701. eCollection 2018 Nov.
5
Predicting the risk of acute care readmissions among rehabilitation inpatients: A machine learning approach.预测康复住院患者急性护理再入院的风险:一种机器学习方法。
J Biomed Inform. 2018 Oct;86:143-148. doi: 10.1016/j.jbi.2018.09.009. Epub 2018 Sep 18.
6
Prediction of Incident Hypertension Within the Next Year: Prospective Study Using Statewide Electronic Health Records and Machine Learning.预测未来一年内高血压的发病情况:一项使用全州电子健康记录和机器学习的前瞻性研究。
J Med Internet Res. 2018 Jan 30;20(1):e22. doi: 10.2196/jmir.9268.
7
The Danish Medical Birth Register.丹麦医学出生登记处。
Eur J Epidemiol. 2018 Jan;33(1):27-36. doi: 10.1007/s10654-018-0356-1. Epub 2018 Jan 19.
8
Efficiency or equity? Simulating the impact of high-risk and population intervention strategies for the prevention of disease.效率还是公平?模拟高风险和人群干预策略对疾病预防的影响。
SSM Popul Health. 2016 Nov 19;3:1-8. doi: 10.1016/j.ssmph.2016.11.002. eCollection 2017 Dec.
9
Neural Network-Based Coronary Heart Disease Risk Prediction Using Feature Correlation Analysis.基于神经网络并运用特征相关性分析的冠心病风险预测
J Healthc Eng. 2017;2017. doi: 10.1155/2017/2780501.
10
Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: The Henry Ford ExercIse Testing (FIT) project.使用SMOTE和集成机器学习方法预测糖尿病:亨利·福特运动测试(FIT)项目。
PLoS One. 2017 Jul 24;12(7):e0179805. doi: 10.1371/journal.pone.0179805. eCollection 2017.